News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
764,963 Results
Type
Article (58588)
Company Profile (386)
Press Release (705989)
Section
Business (218120)
Career Advice (2288)
Deals (37412)
Drug Delivery (117)
Drug Development (85773)
Employer Resources (179)
FDA (17401)
Job Trends (16167)
News (369613)
Policy (36415)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (5)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (7)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2910)
Academic (1)
Accelerated approval (5)
Adcomms (25)
Allergies (87)
Alliances (53506)
ALS (93)
Alzheimer's disease (1453)
Antibody-drug conjugate (ADC) (129)
Approvals (17388)
Artificial intelligence (272)
Autoimmune disease (22)
Automation (14)
Bankruptcy (378)
Best Places to Work (12442)
BIOSECURE Act (21)
Biosimilars (110)
Biotechnology (273)
Bladder cancer (64)
Brain cancer (29)
Breast cancer (270)
Cancer (2152)
Cardiovascular disease (182)
Career advice (1914)
Career pathing (31)
CAR-T (153)
Cell therapy (428)
Cervical cancer (21)
Clinical research (69217)
Collaboration (832)
Compensation (498)
Complete response letters (25)
COVID-19 (2791)
CRISPR (44)
C-suite (230)
Cystic fibrosis (106)
Data (2052)
Decentralized trials (2)
Denatured (30)
Depression (50)
Diabetes (269)
Diagnostics (6733)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (123)
Drug pricing (117)
Drug shortages (31)
Duchenne muscular dystrophy (89)
Earnings (90193)
Editorial (37)
Employer branding (23)
Employer resources (153)
Events (121571)
Executive appointments (695)
FDA (18589)
Featured Employer (56)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (744)
Gene editing (112)
Generative AI (27)
Gene therapy (312)
GLP-1 (790)
Government (5010)
Grass and pollen (5)
Guidances (49)
Healthcare (20582)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (120)
Indications (27)
Infectious disease (2936)
Inflammatory bowel disease (144)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (90)
Interviews (352)
IPO (17181)
IRA (48)
Job creations (4194)
Job search strategy (1639)
Kidney cancer (10)
Labor market (34)
Layoffs (500)
Leadership (19)
Legal (8910)
Liver cancer (75)
Lung cancer (316)
Lymphoma (139)
Machine learning (4)
Management (59)
Manufacturing (300)
MASH (66)
Medical device (14474)
Medtech (14479)
Mergers & acquisitions (20725)
Metabolic disorders (712)
Multiple sclerosis (76)
NASH (18)
Neurodegenerative disease (100)
Neuropsychiatric disorders (29)
Neuroscience (1995)
NextGen: Class of 2025 (7249)
Non-profit (4906)
Northern California (2524)
Now hiring (37)
Obesity (389)
Opinion (240)
Ovarian cancer (76)
Pain (86)
Pancreatic cancer (78)
Parkinson's disease (151)
Partnered (21)
Patents (214)
Patient recruitment (101)
Peanut (50)
People (61450)
Pharmaceutical (82)
Pharmacy benefit managers (20)
Phase I (21531)
Phase II (30323)
Phase III (22702)
Pipeline (1100)
Podcasts (76)
Policy (133)
Postmarket research (2944)
Preclinical (9310)
Press Release (71)
Prostate cancer (99)
Psychedelics (33)
Radiopharmaceuticals (266)
Rare diseases (399)
Real estate (6542)
Recruiting (68)
Regulatory (24622)
Reports (46)
Research institute (2587)
Resumes & cover letters (386)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (130)
Series B (85)
Service/supplier (15)
Sickle cell disease (57)
Southern California (2189)
Special edition (16)
Spinal muscular atrophy (159)
Sponsored (31)
Startups (3969)
State (2)
Stomach cancer (16)
Supply chain (67)
Tariffs (13)
The Weekly (44)
United States (22548)
Vaccines (735)
Venture capitalists (38)
Webinars (12)
Weight loss (277)
Women's health (36)
Worklife (17)
Date
Today (86)
Last 7 days (535)
Last 30 days (2704)
Last 365 days (35073)
2025 (8953)
2024 (37160)
2023 (42145)
2022 (53451)
2021 (58241)
2020 (57083)
2019 (50382)
2018 (38183)
2017 (34944)
2016 (35182)
2015 (41169)
2014 (34892)
2013 (30490)
2012 (32633)
2011 (33246)
2010 (32392)
Location
Africa (899)
Alabama (56)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (43201)
Australia (7245)
California (5807)
Canada (1923)
China (503)
Colorado (263)
Connecticut (280)
Delaware (133)
Europe (96425)
Florida (860)
Georgia (209)
Idaho (61)
Illinois (555)
India (26)
Indiana (309)
Iowa (9)
Japan (148)
Kansas (105)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (899)
Massachusetts (4485)
Michigan (226)
Minnesota (399)
Mississippi (2)
Missouri (85)
Montana (31)
Nebraska (25)
Nevada (59)
New Hampshire (68)
New Jersey (1679)
New Mexico (31)
New York (1665)
North Carolina (1047)
North Dakota (8)
Northern California (2524)
Ohio (200)
Oklahoma (15)
Oregon (37)
Pennsylvania (1296)
Puerto Rico (10)
Rhode Island (31)
South America (1286)
South Carolina (19)
South Dakota (1)
Southern California (2189)
Tennessee (97)
Texas (869)
Utah (173)
Virginia (143)
Washington D.C. (63)
Washington State (548)
West Virginia (3)
Wisconsin (52)
764,963 Results for "repro med systems inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Kane Biotech Signs Worldwide License Agreement with Montreal-Based I-MED Pharma Inc.First Commercial Agreement for DispersinB®
Kane Biotech Inc. announces that it has entered into a worldwide license agreement with I-MED Pharma Inc. (“I-MED Pharma” or “I-MED”) for the DispersinB ® technology.
June 25, 2024
·
3 min read
Press Releases
Inspire Medical Systems, Inc. to Report First Quarter 2025 Financial Results on May 5, 2025
April 1, 2025
·
1 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Healthcare Forum
March 6, 2025
·
1 min read
Press Releases
EssilorLuxottica acquires the Canadian med-tech start-up Cellview
February 11, 2025
·
1 min read
Press Releases
Nurix Therapeutics Appoints Drug Development Expert Roy D. Baynes, MB.Bch., M.Med., Ph.D., to Its Board of Directors
March 14, 2025
·
5 min read
Policy
AbSolutions Med, Inc. Receives FDA Breakthrough Device Designation for its REBUILD™ Bioabsorbable Abdominal Wall Closure Device
AbSolutions Med, Inc., a privately held medical device company, announced that the Food and Drug Administration has granted Breakthrough Device Designation for its REBUILD Bioabsorbable abdominal wall closure device.
January 24, 2024
·
2 min read
Press Releases
Tivic Health Systems, Inc. Announces Reverse Stock Split
March 5, 2025
·
6 min read
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis technology platform to address significant healthcare needs, today announced its PressureSafe™ decision support device has received U.S. Food and Drug Administration (FDA) listing or the indication of pressure injuries.
April 5, 2024
·
4 min read
Press Releases
Clinical Data from Open-Label DAFFODIL™ Study Evaluating Long-term Safety of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Med
March 6, 2025
·
8 min read
Genetown
Vesigen to Present at the 2024 Cell and Gene Meeting on the Med
Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for gene editors, RNA, and protein-based therapeutics, today announced that Paulash Mohsen, Chief Executive Officer, will present at the 2024 Cell and Gene Meeting on the Med on April 10th at 10:45 AM CET in Rome, Italy.
April 3, 2024
·
1 min read
1 of 76,497
Next